🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🇦🇹 Vienna, here we are! Walk with us, and we will take you to where it all happens: Quibim's booth. 📍Booth AI-16, Expo X1 – AI area Book a demo here 👉 bit.ly/41vYADy #ECR2025 #ECR25 #Radiomics #MedicalImaging #radiology

𝐅𝐫𝐨𝐦 𝐢𝐦𝐚𝐠𝐢𝐧𝐠 𝐭𝐨 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧, 𝐲𝐨𝐮𝐫 𝐝𝐚𝐭𝐚 𝐢𝐬 𝐧𝐨𝐰 𝐢𝐧 𝐲𝐨𝐮𝐫 𝐡𝐚𝐧𝐝𝐬. 📍Visit booth AI-16, Expo X1 – AI area or book a demo to discover more about QP-Insights. bit.ly/41vYADy #ECR2025 #MedicalImaging #AIinHealthcare

And just like that, #ECR2025 has come to an end! After five intense days of inspiring conversations and stimulating advances in medical imaging, radiomics, precision medicine, and AI-driven technologies, it's time to say goodbye. 📸 To close this wonderful congress, we share

Prostate cancer is the most common cancer among men in the UK, yet there’s still no national screening program. Early detection saves lives, and that’s why we’re proud to support ProstateCancerResearch in the #ProactiveForYourProstate initiative. Will you join us in making prostate cancer

📢 Have you booked your place? Today is our webinar in collaboration with SEFM on Medical Imaging, Radiomics, and its Oncological applications. Details 👇🏻 📅 March 11 | 17:00 (CET). 🎙 Speaker: Carmen Prieto de la Lastra. 🎤 Moderator: Diego Garcia Pinto Secure your

🌍 We're in Crete for the final ProCAncer-I consortium meeting! It's been an amazing journey, and we are very proud of our contributions to the project, leading key areas such as: ✅ Advanced annotation tool for prostate segmentation ✅ Model drift detection in production ✅

🚀 We are at the 40th Annual Congress of the European Association of Urology (EAU) in Madrid! Find us at booth A73, where we will be showcasing the latest advances in QP-Prostate CAD, our AI-based platform for prostate segmentation and lesion detection. European Association of Urology (EAU) #EAU2025

Ahead of #ECR2025, we had the privilege of speaking with Professor Shonit Punwani—an expert in MRI technology and #prostatecancer imaging. As a UCL Professor, UCLH Consultant Radiologist & Quibim Medical Advisor, he shared key insights on groundbreaking advances shaping

🏆 We’re thrilled to share that Quibim has secured 3rd place in the 50-100 employees category of Spain’s #BestWorkplaces25! This recognition by Great Place to Work Spain reflects our commitment to a people-first culture and workplace well-being. A huge thank you to our incredible team—let’s

CADt, CADe, CADx – What’s the Difference? ⚡ 𝐂𝐀𝐃𝐭: Identifies potentially urgent cases without making a diagnosis. 🩺 𝐂𝐀𝐃𝐞: Flags suspicious regions on medical images to assist as a second reader. 🔬 𝐂𝐀𝐃𝐱: Analyzes and characterizes lesions to support diagnostic

With renewed leadership, FDA clearance for QP-Prostate CAD and a $50M Series A, Quibim enters a new era of growth and strategic expansion that will certainly scale and shape the future of precision healthcare. Introducing our new Board of Directors: bit.ly/4i6Qczc

🇳🇱Angel Alberich-Bayarri will join the stage at ECIO in Rotterdam to discuss: 𝘌𝘵𝘩𝘪𝘤𝘢𝘭, 𝘗𝘳𝘢𝘤𝘵𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘊𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘷𝘦 𝘜𝘴𝘦𝘴 𝘰𝘧 𝘈𝘐 𝘪𝘯 𝘐𝘯𝘵𝘦𝘳𝘷𝘦𝘯𝘵𝘪𝘰𝘯𝘢𝘭 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺. Don't miss it! #AIinHealthcare #EthicalAI #ECIO2025

That’s a wrap for #AUA2025! From insightful demos to engaging conversations with leading experts, we’re thrilled with the impact QP-Prostate CAD is making. Explore QP-Prostate® CAD 👉 bit.ly/44fUEIL 📅 Book a demo: bit.ly/3GaahY5 #AIinHealth #Urology

We're ready for #ASCO2025! With four accepted abstracts and the newest QP-Insights features at our booth, Quibim's presence at ASCO underscores our strong commitment to transform #healthcare. 📩 Book a demo here: bit.ly/44H32Bq

Today the last Consortium Meeting of the #ProCanAid project, coordinated by Quibim and with the collaboration of Universidad Zaragoza and IIS La Fe, was held. This project is now complete, but its achievements are sure to improve the future of precision medicine. Thank you to all partners!

Global events like #ASCO2025 reveal major strides in #oncology—but can public healthcare systems keep up with the promise of precision medicine? Dive into the full interview: bit.ly/4mHTQDs

The 13th European Society of Urogenital Radiology prostate MRI course is being held today in Cambridge. We are grateful that our team can hear directly from radiologists and oncologists to help us better understand their challenges, refine our solutions and make a meaningful contribution to #ProstateCancer.